FDA.reportPublic FDA data

ranolazine 1 GM Oral Granules

RxCUI
2594753
RxNorm name
ranolazine 1 GM Oral Granules
Display name
ranolazine 1 GM Oral Granules
Full name
ranolazine 1 GM Oral Granules
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ASPRUZYO SPRINKLERANOLAZINESUN PHARMACEUTICAL INDUSTRIES, INC.dd9f81e4-50da-4551-aed5-559d304df42e2025-01-29Warnings, Adverse reactionsExact identifier
rxcui: 2594753

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
dd9f81e4-50da-4551-aed5-559d304df42eranolazine 1000 MG Oral Granules [PSN] · ranolazine 1000 MG Oral Granules [SCD] · ranolazine 1 GM Oral Granules [SY]33These highlights do not include all the information needed to use ASPRUZYO SPRINKLE safely and effectively. See full prescribing information for ASPRUZYO SPRINKLE. ASPRUZYO SPRINKLE TM (ranolazine) extended-release granules, for oral use Initial U.S. Approval: 200620250129